Nanjing Vazyme Biotech Co., Ltd.

SSE:688105.SS

22.71 (CNY) • At close June 13, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Omzet 284.655391.987336.639343.611299.501417.435298.258268.843302.1941,263.976685.295644.375975.338579.997463.07283.921541.64426.203344.791586.195207.265
Kosten van de omzet 87.19123.331101.08126.71287.256142.41394.44763.57294.676484.389207.101172.934246.087179.58262.42667.91140.92943.13338.7739.89111.838
Brutowinst 197.465268.656235.559216.9212.246275.022203.811205.271207.519779.587478.194471.442729.251400.415400.644216.009500.711383.07306.02546.304195.428
Brutowinstmarge 0.6940.6850.70.6310.7090.6590.6830.7640.6870.6170.6980.7320.7480.690.8650.7610.9240.8990.8880.9320.943
Onderzoek- en ontwikkelingskosten 66.46976.59472.02261.12370.76381.76874.4986.97984.908126.211112.92585.81471.15782.45863.34746.32638.19240.17938.22400
Algemene en administratieve kosten 0-103.491137.939-29.38753.875-117.127140.952-34.24866.293-75.985134.818-2.78149.079-30.90978.43945.63723.766-8.66436.49300
Verkoop- en marketingkosten 0-150.928251.833114.628103.028143.191102.415123.904103.177176.925141.949113.6189.918117.97997.88855.79447.80660.75945.54500
Verkoop-, algemene en administratieve kosten 157.246-254.419389.772162.411158.54210.639243.36789.656169.47100.94276.767110.829138.99787.07176.326101.62474.44752.09582.03800
Overige kosten -20.578487.388-6.428-3.091-8.702-59.915-10.8281.036-13.157195.736-63.92165.550.498-4.5-2.708-159.412-109.164-3.1620.015-139.372-60.168
Bedrijfskosten 203.136318.856243.703226.624238.005352.322210.182261.897241.22422.887325.771262.193210.652253.785210.032-159.412-109.164132.778107.713-139.372-60.168
Bedrijfsresultaat -5.345-50.2-8.144-9.724-25.76-77.39.534-40.003-33.702-129143.395197.964505.135145.429177.56356.598391.548247.314183.511406.932135.26
Bedrijfsresultaat ratio -0.019-0.128-0.024-0.028-0.086-0.1850.032-0.149-0.112-0.1020.2090.3070.5180.2510.3830.1990.7230.580.5320.6940.653
Totaal overige inkomsten en kosten netto 1.0740.1680.15511.8593.4469.833-10.8281.036-1.163-108.1240.4330.137-0.045-4.5-1.865-0.046-0.282-3.1620.015-7.758-2.853
Inkomen voor belasting -4.271-50.033-7.9892.135-2.365-7.467-1.293-38.966-67.988-237.124143.323198.101505.089140.929175.69956.552391.266244.152183.525399.174132.407
Inkomen voor belasting ratio -0.015-0.128-0.0240.006-0.008-0.018-0.004-0.145-0.225-0.1880.2090.3070.5180.2430.3790.1990.7220.5730.5320.6810.639
Belastingkosten -6.128-13.398-9.695-8.295-7.24-12.321-5.566-8.186-16.779-81.1337.76715.51973.7312.85617.3499.344-54.41227.5131.42388.379-41.69
Nettowinst 1.91-36.251.99710.9435.2165.4334.704-30.47-51.209-155.991135.794182.582431.359128.072158.35955.344336.514216.642152.102339.051113.93
Nettowinstmarge 0.007-0.0920.0060.0320.0170.0130.016-0.113-0.169-0.1230.1980.2830.4420.2210.3420.1950.6210.5080.4410.5780.55
WPA (Winst Per Aandeel) 0.005-0.0920.0050.0280.0130.0140.012-0.076-0.13-0.390.340.461.080.320.40.140.930.540.380.850.28
Verwaterde WPA 0.005-0.0920.0050.0280.0130.0130.012-0.076-0.13-0.390.340.461.080.320.40.140.930.540.380.850.28
EBITDA 2.727.098-0.98762.0426.598-21.50766.76533.276-28.544-158.165220.71234.831543.57168.621201.83873.905391.649243.755199.519337.236195.428
EBITDA ratio 0.010.018-0.0030.1810.022-0.0520.2240.124-0.094-0.1250.3220.3640.5570.2910.4360.260.7230.5720.5790.5750.943